Nurse Practitioner, Family · Collinsville, AL
NPI
1629516299
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
52 S Valley Ave Ste B
Collinsville, AL, 35961
Phone (256) 524-3090
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$800K
9,791 prescriptions
Company payments, 2025
$182
From 8 companies
Medicare prescription drug claims, 2024
In 2024, the drug Virginia K Rutledge prescribed most often to Medicare patients was Losartan Potassium, with 312 prescriptions and refills. In total Virginia K Rutledge wrote 9,791 Medicare prescriptions that cost $800K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Losartan Potassium Generic | 312 | 638 | 73 | $3,145 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 305 | 347 | 89 | $9,682 |
| Omeprazole Generic | 296 | 631 | 77 | $2,524 |
| Tizanidine Hcl Generic | 255 | 303 | 48 | $2,576 |
| Levothyroxine Sodium Generic | 224 | 410 | 49 | $2,350 |
| Amlodipine Besylate Generic | 218 | 490 | 59 | $1,523 |
| Lisinopril Generic | 215 | 543 | 61 | $1,222 |
| Buspirone Hcl Generic | 205 | 302 | 48 | $1,637 |
| Furosemide Generic | 197 | 281 | 43 | $466 |
| Hydrochlorothiazide Generic | 197 | 443 | 52 | $583 |
| Potassium Chloride Generic | 189 | 273 | 53 | $1,685 |
| Atorvastatin Calcium Generic | 177 | 412 | 46 | $1,752 |
| Montelukast Sodium Generic | 170 | 332 | 40 | $1,584 |
| Fluticasone Propionate Generic | 157 | 212 | 52 | $1,719 |
| Meloxicam Generic | 152 | 250 | 35 | $387 |
Brand drugs: 1,182 claims; generic drugs: 8,554 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Virginia K Rutledge $182 ($182 in general payments such as food, travel and fees) from 8 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $33.07.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.